Jihong Chen Selected Research

Jihong Chen Research Topics

Disease

8	Polyneuropathies (Polyneuropathy) 01/2021 - 09/2017
8	Amyloidosis 01/2021 - 09/2017
4	Neoplasms (Cancer) 01/2021 - 12/2006
2	Hyperlipidemias (Hyperlipidemia) 06/2022 - 04/2022
2	Body Weight (Weight, Body) 11/2020 - 01/2018
2	Diabetic Neuropathies (Diabetic Neuropathy) 09/2020 - 09/2017
2	Chronic Renal Insufficiency 01/2020 - 01/2020
2	Transthyretin-Related Hereditary Amyloidosis 01/2019 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 01/2017
2	Multiple Organ Failure (MODS) 11/2015 - 12/2012
2	Epilepsy (Aura) 11/2008 - 01/2005
1	Fatty Liver 06/2022
1	Hypercholesterolemia 04/2022
1	Poisoning 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Acute Lung Injury 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 01/2022
1	Hyperplasia 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Arteriovenous Fistula 01/2022
1	Rheumatoid Arthritis 01/2021
1	Acute Intermittent Porphyria (Porphyria, Acute) 11/2020
1	Porphyrias (Porphyria) 11/2020
1	Pain (Aches) 11/2020
1	Injection Site Reaction 11/2020
1	Nasopharyngeal Carcinoma 08/2020
1	Orthostatic Intolerance 03/2020
1	Flushing 01/2020
1	Proteinuria 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Disease Progression 01/2019
1	Ovarian Epithelial Carcinoma 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 10/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2016

Drug/Important Bio-Agent (IBA)

9	patisiranIBA 01/2021 - 09/2017
7	Prealbumin (Transthyretin)IBA 01/2021 - 01/2019
4	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2018 - 04/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2016
3	Valproic Acid (Depakote)FDA LinkGeneric 11/2008 - 01/2005
3	Histone Deacetylase InhibitorsIBA 11/2008 - 01/2005
2	LDL CholesterolIBA 06/2022 - 04/2022
2	CholesterolIBA 06/2022 - 04/2022
2	gamma-oryzanolIBA 06/2022 - 04/2022
2	oxidized low density lipoproteinIBA 06/2022 - 04/2022
2	Triglycerides (Triacylglycerol)IBA 06/2022 - 04/2022
2	Bexarotene (LGD1069)FDA Link 01/2021 - 02/2016
2	CreatinineIBA 11/2020 - 01/2020
2	Insulin ReceptorIBA 01/2018 - 04/2015
2	PlatinumIBA 01/2018 - 09/2017
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 01/2017
1	Amino Acids FDA Link 06/2022
1	Tyrosine (L-Tyrosine)FDA Link 06/2022
1	HDL CholesterolIBA 04/2022
1	LipidsIBA 04/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	ParaquatIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	PPAR gammaIBA 01/2022
1	Heme Oxygenase-1IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Dystroglycans (Dystroglycan)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	InotersenIBA 01/2021
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	PorphobilinogenIBA 11/2020
1	givosiranIBA 11/2020
1	Hemin (Panhematin)FDA Link 11/2020
1	Transaminases (Aminotransferases)IBA 11/2020
1	Acute Hepatic PorphyriaIBA 11/2020
1	AntioxidantsIBA 10/2020
1	Selenoproteins (Selenoprotein)IBA 10/2020
1	Thioredoxin-Disulfide ReductaseIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	insulin receptor tyrosine kinaseIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Bevacizumab (Avastin)FDA Link 10/2016
1	tivozanibIBA 10/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2016
1	Antineoplastic Agents (Antineoplastics)IBA 10/2016
1	LipopolysaccharidesIBA 11/2015
1	AntigensIBA 11/2015

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2005
6	RNAi Therapeutics 11/2020 - 09/2017
3	Drug Therapy (Chemotherapy) 09/2017 - 04/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2020
1	Renal Dialysis (Hemodialysis) 01/2022
1	Intravenous Administration 11/2020
1	Radiotherapy 08/2020